REGENXBIO, Inc. (RGNX)

8.72 -0.42 (-4.60%) USD  |  NASDAQ  |  Mar 05, 16:00
8.71 -0.01 (-0.11%) After-Hours: 04:40
More

REGENXBIO EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. --
BioMarin Pharmaceutical, Inc. --
Omeros Corp. --
Ultragenyx Pharmaceutical, Inc. --
CytomX Therapeutics, Inc. --